MDX - PowerPoint PPT Presentation

1 / 93
About This Presentation
Title:

MDX

Description:

?????????. ??????. ????. ????????????,?????????????Benicar? ... ???????Cymbalta (Duloxetine),?????????? ???????????,????????????????????? Lipitor (Atorvastatin) ... – PowerPoint PPT presentation

Number of Views:85
Avg rating:3.0/5.0
Slides: 94
Provided by: Micro96
Category:
Tags: mdx | cymbalta

less

Transcript and Presenter's Notes

Title: MDX


1
?MDX?????? ????
  • ?????????????
  • ??? ??
  • April 26, 2006

2
??MDX?????
  • ????
  • ????
  • ??
  • ???
  • ????
  • ??????
  • ????????????
  • ?????
  • ???????
  • ??????
  • ?????????
  • ??????
  • ????

3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
  • ????????????,?????????????Benicar?,??????????

9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
Olmesartan (Benicar?)
15
(No Transcript)
16
  • ????? acetaminophen ??,?????? acetylcystein
    ???????

17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
  • LOADING DOSE of 150 mg/kg in 200 mL of D5W over
    15 min
  • FIRST MAINTENANCE DOSE of 50 mg/kg in 500 mL of
    D5W over 4 hours
  • SECOND MAINTENANCE DOSE of 100 mg/kg in 1000 mL
    of D5W over 16 hours

22
  • Acetaminophen poisoning
  • I.V. (unlabeled)
  • Loading dose 140 mg/kg, followed by 70 mg/kg
    q4h, for a total of 13 doses (loading dose and 48
    hr of treatment) infuse each dose over 1 hr.

Loading dose of 150 mg/kg in 200 mL of D5W over
15 min 1st maintenace dose of 50 mg/kg in 500 mL
of D5W over 4 hours 2nd maintenance dose of 100
mg/kg in 1000 mL of D5W over 16 hours
23
  • FORTY-EIGHT HOUR PROTOCOL (not a standard dosing
    regimen) Dilute 20 solution 15 in D5W and give
    slowly over one hour.
  • The initial dose is 140 mg/kg, followed by 70
    mg/kg q4h for a total of 13 doses (Smilkstein et
    al, 1991).

24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
  • ??????,??????Uroprin? (Phenazopyridine????/??)?

28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
  • ????????????,??????,????????????
  • (Nestmann Nieren-Tonikum S)

33
(No Transcript)
34
Bruchkraut
35
(No Transcript)
36
Hauhechelwurzel
37
(No Transcript)
38
  • ???????Cymbalta? (Duloxetine),??????????

39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
(No Transcript)
44
(No Transcript)
45
  • ???????????,?????????????????????
  • Lipitor? (Atorvastatin)
  • Adalat OROS? (Nifedipine)
  • Bokey? (Aspirin)
  • Micardis? (Telmisartan)

46
(No Transcript)
47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
(No Transcript)
52
(No Transcript)
53
(No Transcript)
54
(No Transcript)
55
  • Repaglinide (NovoNorm?)?????gemfibrozil
    (Lopid?)?????

56
(No Transcript)
57
(No Transcript)
58
(No Transcript)
59
(No Transcript)
60
(No Transcript)
61
  • ???????? (prednisolone) ????,???????????????,????

62
(No Transcript)
63
(No Transcript)
64
(No Transcript)
65
(No Transcript)
66
(No Transcript)
67
  • ????????Clomiphene,????????

68
Clomiphene
  • DRUGDEX DRUG EVALUATIONS
  • Patient Instructions
  • USP DI(R) Advice for the Patient(R)
  • Proper Use of This Medicine

If a Dose is Missed Take the missed dose as
soon as you remember. - Tell your doctor if you
have missed any doses, because this may affect
your treatment.
If you miss a dose of this medicine, take it as
soon as possible. If you do not remember until it
is time for the next dose, take both doses
together then go back to your regular dosing
schedule. If you miss more than one dose, check
with your doctor.
69
  • ??Wintermin? (Chlorpromazine)???,????????,????????
    ???

70
(No Transcript)
71
(No Transcript)
72
(No Transcript)
73
(No Transcript)
74
  • Amiodarone (Cordarone?)?????????
    ??????ceftriaxone???????

75
(No Transcript)
76
(No Transcript)
77
Martindale (amiodarone)
78
Martindale (amiodarone)
79
USP-DI (amiodarone)
80
(No Transcript)
81
(No Transcript)
82
  • ???Wilsons disease,????Penicillamine 300 mg
    qd,??????,????????? ??????????

83
(No Transcript)
84
(No Transcript)
85
D There is positive evidence of human fetal
risk, but the benefits from use in pregnant women
may be acceptable despite the risk (e.g., if the
drug is needed in a life-threatening situation or
for a serious disease for which safer drugs
cannot be used or are ineffective).
86
(No Transcript)
87
(No Transcript)
88
(No Transcript)
89
(No Transcript)
90
(No Transcript)
91
(No Transcript)
92
(No Transcript)
93
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com